# Review-area modules

Use corporate/entity and transaction-structure review as the common spine. Add a
module only when the target, deal structure, repository, or user-defined scope
activates it. An omitted module means `outside current scope`, not `no issue`.

Each new module should contain five fields:

- **Trigger** — facts that activate the module.
- **Questions** — decisions the review must support.
- **Evidence** — documents, records, and interviews expected.
- **Outputs** — matrices, reconciliations, findings, and open items produced.
- **Escalation** — issues requiring specialist or local counsel.

## Corporate, entity, capitalization, and deal structure

- **Trigger:** Always.
- **Questions:** What entities and assets exist; who owns them; what is being
  acquired; which approvals, transfers, payoffs, releases, or separations are
  required; what remains with seller?
- **Evidence:** Formation and governing documents, amendments, minute books,
  consents, good-standing and qualification records, organizational charts, cap
  tables, ledgers, certificates, equity plans and awards, investor rights,
  stockholder agreements, prior transaction documents, debt and lien records,
  intercompany arrangements, and current transaction drafts.
- **Outputs:** Entity/ownership reconciliation, capitalization exceptions,
  approval map, structure dependencies, payoff/release list, intercompany and TSA
  needs, and identified closing or post-closing actions.
- **Escalation:** Defective authorization, disputed ownership, unrecorded
  issuances, fiduciary/conflict questions, appraisal rights, insolvency, fraudulent
  transfer, securities-law questions, or structure-specific tax consequences.

## Material commercial contracts

- **Trigger:** Revenue, spend, strategic dependency, exclusivity, data/IP access,
  unusual liability, or another user-defined materiality threshold.
- **Questions:** Can the agreement continue through the proposed transaction;
  what can terminate or reprice; what consents/notices apply; what obligations or
  concentrations affect value or integration?
- **Evidence:** Complete executed agreement, orders/SOWs, amendments, incorporated
  online terms, side letters, waivers, notices, performance and dispute history,
  customer/vendor concentration schedules, and management explanations.
- **Outputs:** Contract inventory; separate assignment/change-of-control matrix;
  term/renewal/termination matrix; exclusivity, minimums, MFN/pricing, liability,
  indemnity, IP/data, service-level, audit, and dispute findings; consent plan.
- **Escalation:** Ambiguous transaction triggers, regulated counterparties,
  government contracts, competition restraints, uncapped or uninsured exposure,
  or missing operative documents.

## Intellectual property, technology, and data

- **Trigger:** Proprietary products, brands, content, software, data, AI systems,
  regulated data, material licenses, or technology-dependent operations.
- **Questions:** Does the target own or validly license what the business needs;
  are chain-of-title, open-source, inbound/outbound license, security, privacy, and
  separation risks understood?
- **Evidence:** Registration and application schedules, assignments, invention
  agreements, licenses, development agreements, source-code and OSS records,
  domain records, security/privacy policies, incident records, assessments,
  vendor/data-processing terms, and systems maps.
- **Outputs:** Ownership and chain-of-title exceptions, license/transfer matrix,
  OSS and third-party component issues, privacy/security incident and compliance
  issues, and separation/remediation needs.
- **Escalation:** Patent validity or freedom-to-operate, source-code audit,
  cybersecurity testing, export controls, biometric/health/children's data, or
  multi-jurisdiction privacy analysis.

## Labor, employment, benefits, and executive compensation

- **Trigger:** Employees, contractors, unions, benefit plans, equity awards,
  retention/change-in-control arrangements, or workforce restructuring.
- **Questions:** What workforce obligations, liabilities, consents, notices,
  payments, vesting, restrictive covenants, or integration constraints may be
  triggered?
- **Evidence:** Census and payroll records, agreements, policies, handbooks,
  contractor files, wage/hour and leave records, immigration files, complaints,
  investigations, CBAs, benefit plan documents and filings, equity awards,
  severance/retention arrangements, and change-in-control calculations.
- **Outputs:** Workforce and classification exceptions, claims/investigation log,
  labor obligations, benefit-plan issues, executive-payment and award-treatment
  matrix, restrictive-covenant issues, and required notices/consents.
- **Escalation:** ERISA, tax-qualified plans, Internal Revenue Code Sections 280G,
  409A or 4999, WARN and state mini-WARN, union successorship, immigration,
  worker classification, pay equity, or multistate restrictive covenants.

## Real estate and environmental

- **Trigger:** Owned or leased property, industrial operations, hazardous
  materials, permits, storage tanks, emissions/discharges, or legacy sites.
- **Questions:** Can sites and permits continue; what transfer, consent, title,
  condition, remediation, closure, or successor-liability issues exist?
- **Evidence:** Deeds, title and surveys, leases and amendments, estoppels and
  SNDAs, zoning records, permits, Phase I/II reports, audits, notices, spills,
  remediation records, waste records, and environmental insurance.
- **Outputs:** Property/lease matrix, transfer and consent requirements, title and
  use exceptions, permit map, recognized environmental conditions, compliance
  history, remediation obligations, and specialist open items.
- **Escalation:** Title opinions, zoning analysis, Phase II or engineering work,
  CERCLA or state-law liability, permit transfers, wetlands, endangered species,
  or material remediation estimates.

## Government contracts

- **Trigger:** Federal, state, local, tribal, or foreign-government customer,
  grant, subcontract, set-aside status, security clearance, or government-funded
  IP.
- **Questions:** What approval, novation, assignment, disclosure, audit,
  suspension/debarment, pricing, cybersecurity, or IP obligations affect the deal?
- **Evidence:** Contract and subcontract files, solicitations, modifications,
  representations/certifications, registrations, audit and investigation records,
  disclosures, cost/pricing files, security requirements, and government rights.
- **Outputs:** Contract/agency matrix, novation or consent plan, compliance and
  disclosure issues, audit exposure, set-aside and clearance dependencies, and IP
  or data restrictions.
- **Escalation:** FAR/DFARS and agency supplements, False Claims Act, export
  controls, classified work, cost accounting, set-aside eligibility, or mandatory
  disclosure.

## Regulatory, healthcare, and industry licensing

- **Trigger:** Regulated products, services, facilities, professionals, payors,
  reimbursement, licenses, certifications, or government investigations.
- **Questions:** Can approvals and reimbursement relationships survive; are
  ownership-change filings, consents, exclusions, repayment, referral, billing,
  quality, or compliance risks material?
- **Evidence:** Licenses, permits, enrollments, accreditations, surveys, billing
  audits, compliance programs, investigations, corrective actions, payor and
  referral arrangements, product approvals, and adverse-event records.
- **Outputs:** License/filing map, ownership-change requirements, compliance and
  repayment issues, investigation history, and closing/integration dependencies.
- **Escalation:** Healthcare fraud and abuse, reimbursement, FDA or other product
  regulation, professional licensing, controlled substances, sanctions, or
  jurisdiction-specific regulatory approval.

## Antitrust and foreign-investment review

- **Trigger:** Horizontal or vertical overlap, concentrated markets, sensitive
  information exchange, restrictive arrangements, reportable size thresholds,
  foreign investment, or national-security-sensitive activities.
- **Questions:** Are filings, waiting periods, consents, clean-team controls, or
  substantive competition/national-security issues implicated?
- **Evidence:** Ownership and revenue data, overlap descriptions, market and
  competitor documents, transaction documents, prior filings, foreign ownership,
  government contracts, export-controlled work, and sensitive-data/assets maps.
- **Outputs:** Filing and jurisdiction issue list, information-sharing protocol,
  substantive issue flags, timing dependencies, and specialist workplan.
- **Escalation:** HSR calculations, state or foreign merger control, CFIUS or
  analogous review, gun-jumping, substantive market definition, or remedies.

## Tax

- **Trigger:** Any acquisition; deepen when structure, elections, attributes,
  cross-border operations, pass-through entities, sales/payroll/property nexus,
  equity compensation, or uncertain positions are material.
- **Questions:** Which tax diligence findings may affect structure, price,
  indemnity, elections, filings, or post-closing integration?
- **Evidence:** Returns, elections, correspondence, audits, tax-sharing
  agreements, attributes, nexus studies, payroll and indirect-tax records,
  transfer-pricing materials, and advisor reports.
- **Outputs:** Factual tax document inventory, open returns/audits, tax-sharing and
  attribute issues, missing specialist analyses, and transaction dependencies.
- **Escalation:** Tax is specialist territory. Do not infer tax consequences,
  attribute availability, Section 338/336(e) treatment, reorganization status,
  partnership allocations, cross-border consequences, or exposure calculations
  without qualified tax review.

## Litigation, investigations, and insurance interface

- **Trigger:** Claims, demands, disputes, investigations, subpoenas, warranties,
  recalls, consent decrees, or recurring customer/employee complaints.
- **Questions:** What is pending, threatened, resolved but continuing, reserved,
  insured, self-insured, or subject to injunction or operational restriction?
- **Evidence:** Pleadings, dockets, correspondence, settlement and release
  agreements, investigation files, reserves, claim histories, insurance policies,
  notices, coverage positions, and management/legal interviews.
- **Outputs:** Matter chronology, exposure and remedy allegations as stated by the
  evidence, status and next dates, coverage-position record, continuing
  obligations, and missing counsel/insurer information.
- **Escalation:** Merits or outcome prediction, privilege waiver, litigation
  strategy, coverage opinion, sanctions, criminal exposure, or regulatory defense.
